ABSTRACT. A cross-sectional survey of a convenient sample of domestic cats from Costa Rica's greater metropolitan area was carried out to determine the prevalence of antibodies against feline herpesvirus type 1 (FHV-1), feline parvovirus (FPV), feline immunodeficiency virus (FIV) and antigens of feline leukemia virus (FeLV). Blood samples were collected from at least 96 cats from June 1998 to December 2001; data related to the individual cats and household variables were obtained using a questionnaire. Antibodies against FHV-1 were found in 71.9% of the cats sampled, but only 25.0% of them had a history of previous vaccination. The prevalence of FPV was 92.8%, and all positive cats showed protective antibodies titres; however, only 16.5% of them were previously vaccinated. Antigens of FeLV were detected in 16.7% of the sampled cats; 11 (64.7%) of the 17 positive cats were older than 1 year at the time of testing. No differences were found between the percentage of seropositive males and females. Antibodies against FIV were detected in 8.8% of the samples tested; 8 (88.8%) of the seropositive cats were older than 1 year of age, and a greater proportion of seropositive males (66.6%) was found. KEY WORDS: feline herpesvirus type 1, feline immunodeficiency virus, feline leukemia virus, feline parvovirus.
Serum samples from a total of 44 wildcats, 28 margays (Leopardus wiedii), 10 ocelots (Leopardus pardalis), four jaguaroundis (Herpailurus yaguaroundi), one oncilla (Leopardus tigrina), and one jaguar (Panthera onca) were obtained between January 2001 and August 2002 from the Profelis Centre for rehabilitation of wild felids, located in the northwestern region of Costa Rica. Forty three samples were tested for antibodies against feline immunodeficiency virus (FIV) and p27 antigen of feline leukemia virus (FeLV), 42 samples for antibodies against feline parvovirus (FPV), and 30 for antibodies against feline calicivirus (FCV). None of the samples contained detectable antibodies against FIV or p27 antigen of FeLV, all samples contained antibodies against FPV, and one sample contained antibodies against FCV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.